MAP3K3 and cutaneous melanoma: We also report a correlation between MAP3K3 expression and the YAP protein abundance in cutaneous melanoma, and we demonstrate the efficient suppression of YAP-associated BRAF inhibitor resistance through MAP3K3 inhibition.